Literature DB >> 19958977

In defense of antimicrobial prophylaxis for prevention of infective endocarditis in patients with hypertrophic cardiomyopathy.

Barry J Maron, Harry Lever.   

Abstract

Entities:  

Mesh：

Year:  2009        PMID： 19958977     DOI： 10.1016/j.jacc.2009.07.050

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN： 0735-1097            Impact factor:   24.094


× No keyword cloud information.
  5 in total

Review 1.  The mitral valve in hypertrophic cardiomyopathy: old versus new concepts.

Authors:  Albert A Hagège; Patrick Bruneval; Robert A Levine; Michel Desnos; Hany Neamatalla; Daniel P Judge
Journal:  J Cardiovasc Transl Res       Date:  2011-09-10       Impact factor: 4.132

2.  Hypertrophic cardiomyopathy: role of current recommendations by the american heart association for infective endocarditis.

Authors:  Natasha Noel; Zahra Naheed
Journal:  Pediatr Cardiol       Date:  2012-05-13       Impact factor: 1.655

Review 3.  Update on hypertrophic cardiomyopathy and a guide to the guidelines.

Authors:  Srijita Sen-Chowdhry; Daniel Jacoby; James C Moon; William J McKenna
Journal:  Nat Rev Cardiol       Date:  2016-09-29       Impact factor: 32.419

4.  Infective endocarditis in hypertrophic cardiomyopathy: A multicenter, prospective, cohort study.

Authors:  Fernando Dominguez; Antonio Ramos; Emilio Bouza; Patricia Muñoz; Maricela C Valerio; M Carmen Fariñas; José Ramón de Berrazueta; Jesús Zarauza; Juan Manuel Pericás Pulido; Juan Carlos Paré; Arístides de Alarcón; Dolores Sousa; Isabel Rodriguez Bailón; Miguel Montejo-Baranda; Mariam Noureddine; Elisa García Vázquez; Pablo Garcia-Pavia
Journal:  Medicine (Baltimore)       Date:  2016-06       Impact factor: 1.889

5.  Commentary: Endocarditis in hypertrophic cardiomyopathy: A reason to strengthen the guidelines?

Authors:  Thierry Carrel
Journal:  JTCVS Tech       Date:  2020-11-17
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.